Corbus Pharmaceuticals Holdings (CRBP) Share-based Compensation (2013 - 2025)

Corbus Pharmaceuticals Holdings' Share-based Compensation history runs 13 years deep, the most recent figure standing at $1582.0 for Q3 2025.

• In Q3 2025, Share-based Compensation fell 29.47% year-over-year to $1582.0; the TTM figure through Sep 2025 stood at $3.3 million (up 316.81% YoY), while the FY2024 annual figure was $6.1 million, up 77.09% from the prior year.
• Share-based Compensation was $1582.0 for Q3 2025 at Corbus Pharmaceuticals Holdings, up from $1563.0 in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $2.6 million in Q3 2021 to a low of $982.0 in Q1 2024.
• Historically, Share-based Compensation has averaged $1.2 million across 5 years, with a median of $1.3 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Share-based Compensation slumped 99.9% in 2024, then surged 174441.75% in 2025.
• A 5-year view of Share-based Compensation shows it stood at $1.8 million in 2021, then dropped by 29.23% to $1.3 million in 2022, then slumped by 37.05% to $799000.0 in 2023, then jumped by 104.26% to $1.6 million in 2024, then slumped by 99.9% to $1582.0 in 2025.
• The last three Share-based Compensation figures came in at $1582.0 (Q3 2025), $1563.0 (Q2 2025), and $1.7 million (Q1 2025), per Business Quant data.